Literature DB >> 35115698

Isolated diastolic hypertension is not associated with endothelial dysfunction.

Yiming Han1, Tatsuya Maruhashi1, Masato Kajikawa2, Shinji Kishimoto1, Takayuki Yamaji3, Takahiro Harada3, Yu Hashimoto3, Farina Mohamad Yusoff1, Yukiko Nakano3, Kazuaki Chayama4, Ayumu Nakashima5, Chikara Goto6, Kenichi Yoshimura7, Yukihito Higashi8,9.   

Abstract

Hypertension is associated with an impairment of endothelial function. However, it is unclear whether isolated diastolic hypertension is associated with endothelial dysfunction. The purpose of this study was to investigate the association of endothelial function with isolated diastolic hypertension diagnosed by using two major hypertension guidelines: systolic blood pressure (BP) < 130 mmHg and diastolic BP ≥ 80 mmHg according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline and systolic BP < 140 mmHg and diastolic BP ≥ 90 mmHg according to the 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) hypertension guideline. We measured the flow-mediated vasodilation (FMD) of the brachial artery in subjects without systolic hypertension who were not treated with antihypertensive drugs. Of 3727 subjects (2813 men; mean age: 41.3 ± 10.9 years), 749 (20.1%) had isolated diastolic hypertension according to the 2017 ACC/AHA definition. Multiple logistic regression analysis revealed that isolated diastolic hypertension was not associated with endothelial dysfunction, defined as FMD < 7.0% (OR, 1.15; 95% CI, 0.98-1.35; P = 0.09). Of 4747 subjects (3727 men; mean age: 45.1 ± 10.8 years), 314 subjects (6.6%) had isolated diastolic hypertension according to the ESC/ESH definition. Multiple logistic regression analysis revealed that isolated diastolic hypertension was not associated with endothelial dysfunction after adjusting for age and sex (OR, 1.04; 95% CI, 0.82-1.32; P = 0.76). Isolated diastolic hypertension was not associated with endothelial dysfunction in individuals who were not treated with antihypertensive drugs regardless of the major hypertension guideline definition used.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Endothelial function; Flow-mediated vasodilation; Isolated diastolic hypertension

Mesh:

Substances:

Year:  2022        PMID: 35115698     DOI: 10.1038/s41440-022-00854-y

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  2 in total

Review 1.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

2.  Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery.

Authors:  Tatsuya Maruhashi; Masato Kajikawa; Shinji Kishimoto; Haruki Hashimoto; Yuji Takaeko; Takayuki Yamaji; Takahiro Harada; Yiming Han; Yoshiki Aibara; Farina Mohamad Yusoff; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Ayumu Nakashima; Chikara Goto; Hirofumi Tomiyama; Bonpei Takase; Takahide Kohro; Toru Suzuki; Tomoko Ishizu; Shinichiro Ueda; Tsutomu Yamazaki; Tomoo Furumoto; Kazuomi Kario; Teruo Inoue; Shinji Koba; Kentaro Watanabe; Yasuhiko Takemoto; Takuzo Hano; Masataka Sata; Yutaka Ishibashi; Koichi Node; Koji Maemura; Yusuke Ohya; Taiji Furukawa; Hiroshi Ito; Hisao Ikeda; Akira Yamashina; Yukihito Higashi
Journal:  J Am Heart Assoc       Date:  2020-01-08       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.